NSF Engineering Research Center for Advanced Technologies for the Preservation of Biological Systems (ATP-Bio)

ATP-Bio Logo
Award Amount
$26,000,000
Project Dates
09/01/2020 to 08/25/2025
Principal Investigator

John Bischof, PhD (University of Minnesota), ATP-Bio Director
Mehmet Toner, PhD (Massachusetts General Hospital), ATP-Bio Deputy Director
Guillermo Aguilar, PhD (Texas A&M University)
Kevin Healy, PhD (University of California Berkeley)

Ethics & Public Policy Panel (EP3)
Susan M. Wolf, JD (University of Minnesota), Lead, Ethics & Public Policy Pillar
Timothy Pruett, MD (University of Minnesota), Co-Lead, Ethics & Public Policy Pillar
All Ethics & Public Policy Panel (EP3) members

Center Description

The ERC for Advanced Technologies for the Preservation of Biological Systems (ATP-Bio) aims to stop biological time and radically extend the ability to bank and transport cells, aquatic embryos, tissue, skin, whole organs, microphysiological systems (organs-on-a-chip), and even whole organisms through a team approach to build advanced biopreservation technologies. In order to build a more robust and diverse STEM workforce, especially in the growing number of fields needing biopreservation technologies, ATP-Bio also aims for equitable STEM education across all components of the Center. The integration of Engineering and Workforce Development (EWD) and Diversity and Culture of Inclusion (DCI) across all components of ATP-Bio is aimed at creating a more diverse STEM workforce that understands team science, especially for the growing number of fields needing biopreservation technologies. ATP-Bio will also include sustained and focused analyses of Ethics & Public Policy (EPP) issues so that the Center’s technology will be legally and ethically translated for public benefit.

Together with a large and active group of industrial partners, ATP-Bio aims to produce social benefit through off-the-shelf biopreservation technologies for cell therapies, tissue and organ transplantation, pharmacological research, aquaculture, biodiversity efforts, and many other fields. ATP-Bio will accomplish its goals by engineering technologies for biological systems before cooling, during cooling and stasis at subzero temperatures, and during rewarming to normal biological temperatures. At each stage, ATP-Bio convergent science teams will aim to eliminate or control ice formation, mitigate the toxicity of cryopreservation agents, and eliminate thermal and mechanical stress.

Ethics & Public Policy (EPP) | Ethics & Public Policy Panel (EP3)

The Ethics & Public Policy (EPP) component of this Center will work with Center researchers and an Ethics & Public Policy Panel (EP3) comprised of multidisciplinary national experts in ethics and policy. They will build an integrated and interdisciplinary program of ethics & policy analysis to support research and development of ATP-Bio’s technology for public benefit:

1. Analyze ethics & policy challenges raised by ATP-Bio research & key applications; Identify ethical, legal & societal issues (ELSI) raised by ATP-Bio research & applications; Collaborate within and outside ATP-Bio to analyze ELSI issues in ATP-Bio.

2. Advance ethical development & deployment of ATP-Bio technologies for societal benefit; Conduct ELSI analysis of ATP-Bio technologies anticipating development & deployment; Develop and publish ethics & policy analyses focused on ATP-Bio technologies.

3. Expose ATP-Bio investigators & trainees to EPP questions & methods; Offer events & online portal of ethics & policy resources; Collaborate on research & publication.

4.  Collaborate with NSF & ERCs in Stakeholder Engagement & Impact Collaborative (SEIC); Collaborate across the Gen-4 ERCs in the NSF Stakeholder Engagement & Impact Collaborative (SEIC).

5. Conduct groundbreaking NetEthics project funded by NSF; Analyze challenges facing complex engineering networks like ERCs; Develop tools to advance ethics & responsible conduct of research (RCR) in engineering networks.

Journal of Law, Medicine & Ethics Symposium (2024)

Follow media coverage of ATP-Bio